326 related articles for article (PubMed ID: 25913181)
21. Nasal azelastine for self-medication: modest symptomatic relief from rhinitis.
Prescrire Int; 2007 Aug; 16(90):149. PubMed ID: 17724840
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
[TBL] [Abstract][Full Text] [Related]
23. Allergic Rhinitis: A Review.
Bernstein JA; Bernstein JS; Makol R; Ward S
JAMA; 2024 Mar; 331(10):866-877. PubMed ID: 38470381
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Wober W; Diez Crespo CD; Bähre M
Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
[TBL] [Abstract][Full Text] [Related]
25. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
26. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
McNeely W; Wiseman LR
Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
[TBL] [Abstract][Full Text] [Related]
27. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score.
Sardana N; Santos C; Lehman E; Craig T
Allergy Asthma Proc; 2010; 31(1):5-9. PubMed ID: 20167140
[TBL] [Abstract][Full Text] [Related]
28. Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. Fluticasone Propionate Collaborative Pediatric Working Group.
J Pediatr; 1994 Oct; 125(4):628-34. PubMed ID: 7931889
[TBL] [Abstract][Full Text] [Related]
29. Azelastine and olopatadine in the treatment of allergic rhinitis.
Kaliner MA
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
[TBL] [Abstract][Full Text] [Related]
31. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis.
Yáñez A; Rodrigo GJ
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):479-84. PubMed ID: 12452206
[TBL] [Abstract][Full Text] [Related]
32. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.
Kaszuba SM; Baroody FM; deTineo M; Haney L; Blair C; Naclerio RM
Arch Intern Med; 2001 Nov; 161(21):2581-7. PubMed ID: 11718589
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
35. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
[TBL] [Abstract][Full Text] [Related]
36. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
38. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.
Salib RJ; Howarth PH
Drug Saf; 2003; 26(12):863-93. PubMed ID: 12959630
[TBL] [Abstract][Full Text] [Related]
39. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
Price D; Shah S; Bhatia S; Bachert C; Berger W; Bousquet J; Carr W; Hellings P; Munzel U; Scadding G; Lieberman P
J Investig Allergol Clin Immunol; 2013; 23(7):495-503. PubMed ID: 24654314
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
Golden SJ; Craig TJ
J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S7-12. PubMed ID: 10478514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
